CONMED Corporation (CNMD) financial statements and ratios from SEC XBRL: revenue $1.37B (TTM), net margin 3.4%, revenue growth 0.3% YoY, P/E 24.0. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.37B |
| Net Margin | 3.4% |
| Revenue Growth (YoY) | 0.3% |
| EPS Growth (YoY) | 11.6% |
| FCF Growth (YoY) | 91.2% |
| P/E Ratio | 24.0 |
| EV / EBITDA | 10.4 |
| Price / Book | 1.48 |
| Price / Sales | 1.10 |
| FCF Yield | 10.3% |
| DCF Value (model) | $28.25 |
| DCF Upside vs Price | -45.0% |
| Altman Z-Score | 2.01 (grey) |
| Sector P/E (Healthcare) | 21.6 |
CNMD overview · CNMD earnings · CNMD KPIs · CNMD investor relations · CNMD ownership · CNMD peers · CNMD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.